Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 12, 2024ChemistrySelect

1‐Benzyl‐1H‐indazol‐3‐ol Copper(II) Derivatives as Anticancer Agents: In‐vitro Interaction with DNA/BSA, DFT, Molecular Docking and Cytotoxicity on MCF7 Cells

View Full Paper
Ask AI
Bookmark
Share

Authors

SSShivabasayya V. SalimathJain UniversityMPMadhvesh PathakVellore Institute of Technology University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Salimath et al. (2024) studied this question.

synapsesocial.com/papers/68e796e3b6db643587707f96https://doi.org/10.1002/slct.202304565
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Mixed-ligand copper( ii ) Schiff base complexes: the role of the co-ligand in DNA binding, DNA cleavage, protein binding and cytotoxicity2016 · 190 citations
  2. 2Synthesis of the first mixed ligand Mn (II) and Cd (II) complexes of 4‐methoxy‐pyridine‐2‐carboxylic acid, molecular docking studies and investigation of their anti‐tumor effects in vitro2019 · 80 citations
  3. 3Structural, spectroscopic, molecular docking, thermal and DFT studies on metal complexes of bidentate orthoquinone ligand2019 · 35 citations